Aytu BioScience Depreciation & Amortization 2011-2026 | AYTU

Annual Depreciation & Amortization Aytu BioScience

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
5.38 M	6.72 M	8.82 M	10.1 M	9.2 M	5.71 M	2.73 M	2.59 M	4.36 M	875 K	118 K	97.5 K	58.4 K	53.4 K	6.76 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.1 M	6.76 K	3.79 M

Quarterly Depreciation & Amortization Aytu BioScience

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	803 K	-	100 K	100 K	1.33 M	-	200 K	300 K	924 K	-	1.84 M	1.85 M	2.3 M	4.5 M	500 K	400 K	2.68 M	5.35 M	68 K	18 K	2.04 M	4.01 M	2.09 M	16 K	869 K	2.16 M	869 K	16 K	557 K	1.23 M	557 K	329 K	653 K	1.32 M	653 K	26 K	822 K	1.72 M	822 K	12 K	129 K	242 K	129 K	1.2 K	24.6 K	2.39 K	-	1.2 K	3.75 K	2.53 K	1.2 K	1.29 K	4.79 K	3.32 K	1.29 K	1.66 K	5.1 K	3.36 K	1.66 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.35 M	1.2 K	798 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	55.7 M	$ 311.28	0.91 %	$ 40.8 B	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Anavex Life Sciences Corp. AVXL	1.25 K	$ 4.06	3.57 %	$ 346 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Adagene ADAG	723 K	$ 2.89	1.4 %	$ 163 M	China
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.83	-2.66 %	$ 4.53 M	China
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	780 M	$ 197.99	1.27 %	$ 29 B	USA
Bristol-Myers Squibb Company BMY	4.01 B	$ 60.66	1.34 %	$ 123 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Corcept Therapeutics Incorporated CORT	795 K	$ 39.76	3.7 %	$ 4.1 B	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Autolus Therapeutics plc AUTL	7.55 M	$ 1.43	3.62 %	$ 365 M	Britain
Amneal Pharmaceuticals AMRX	62.6 M	$ 14.79	1.09 %	$ 4.57 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 52.55	7.4 %	$ 4.73 B	Schweiz
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA